69
Participants
Start Date
August 16, 2021
Primary Completion Date
February 23, 2022
Study Completion Date
February 23, 2022
Cephalexin
1000 mg PO QID for 7 days
Cephalexin + placebo
500 mg PO QID plus oral placebo for 7 days
The Ottawa Hospital, Ottawa
Lead Sponsor
The Ottawa Hospital Academic Medical Association
OTHER
Canadian Association of Emergency Physicians
INDUSTRY
Ottawa Hospital Research Institute
OTHER